$VERU

Veru Inc

  • NASDAQ CAPITAL MARKET
  • Consumer Non-Durables
  • Household/Personal Care
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$6.87 -

Extented Hours

VOLUME

412,948

DAY RANGE

6.84 - 7.02

52 WEEK

2.3 - 24.57

Join Discuss about VERU with like-minded investors

profile
@Carlos-carvan58 #ivtrades
recently

On watch $VERU

68 Replies 8 πŸ‘ 14 πŸ”₯

profile
@viking #StockTraders.NET
recently

Upside: -RMED +45% (momentum) -LMNL +44% (momentum following FDA approval for its Biologics License Application for Ryplazim) -USCR +28% (to be acquired by Vulcan Materials for $74.00/shr in cash valued at $1.29B) -QTS +21% (to be acquired by Blackstone at $78.00/shr for a total transaction value of $10B) -BNGO +14% (names Jason Priar as its Chief Commercial Officer) -EVFM +14% (momentum) -MIC +12% (confirms to sell Atlantic Aviation unit for $4.48B in cash and assumed debt and reorganization obligations) -CDXC +11% (ChromaDex and Walmart launch Tru Niagen in 3,800 (from 3K prior) Walmart Stores Across the United States) -GIII +8.1% (earnings, guidance) -BLUE +7.4% (announces the Lifting of FDA Clinical Hold for Sickle Cell Disease and ß-Thalassemia Studies) -VERU +5.0% (announces positive data at ASCO) -BIIB +4.7% (Biogen and Bio-Thera announce positive results from Phase 3 study of BAT1806) -NOVN +2.3% (results from Novan’s Exploratory Studies further demonstrate Antimicrobial Effect of NITRICILβ„’ Platform Technology with NVN4100 in Companion Animal Health) -KKR +1.1% (MIC confirms to sell Atlantic Aviation unit for $4.48B in cash and assumed debt and reorganization obligations) Downside: -MOSY -12% (files to sell 1.8M shares at $7.15/shr for a total value of $13M) -PIXY -7.3% (files to sell up to 10.1M shares for holders) -WERN -2.0% (hearing cut at Goldman Sachs to Sell from Neutral) -MSTR -1.2% (to incur $284.5M impairment loss in Q2 due to fluctuations in Bitcoin; files to sell $400M of Senior secured 2028 notes)

90 Replies 11 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

all covered $VERU

64 Replies 15 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

had a $10.6 avg on $VERu wish I held some size

117 Replies 8 πŸ‘ 11 πŸ”₯

profile
@maletone #StockTraders.NET
recently

yikes $VERU

69 Replies 7 πŸ‘ 11 πŸ”₯

PR
@proj8 #StockTraders.NET
recently

short watch $VERU $MVIS $ATNX

53 Replies 13 πŸ‘ 12 πŸ”₯

XX
@xX_Drip_Gawd_Xx #StockTraders.NET
recently

$VERU ANNOUNCES THE PRESENTATION OF POSITIVE PHASE 2 CLINICAL DATA OF ENOBOSARM

62 Replies 15 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$VERU on watch

61 Replies 14 πŸ‘ 9 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

watchlist: $OCGN, $DPW, $VERU, $ATNX.....also watching $SKLZ post earnings

89 Replies 13 πŸ‘ 8 πŸ”₯

profile
@maletone #StockTraders.NET
recently

nice $VERU offering

73 Replies 14 πŸ‘ 6 πŸ”₯

BR
@brAli #StockTraders.NET
recently

$veru Hod break

56 Replies 7 πŸ‘ 10 πŸ”₯

profile
@viking #StockTraders.NET
recently

$VERU earnings tomorrow morn guys..fyi

57 Replies 10 πŸ‘ 12 πŸ”₯

WI
@WINTERTRADE #StockTraders.NET
recently

$veru nice into close

74 Replies 15 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

missed the long on $VERU

72 Replies 7 πŸ‘ 10 πŸ”₯

WI
@WINTERTRADE #StockTraders.NET
recently

ss $veru earlier as well

54 Replies 12 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

almost got clipped on $VERU but covered for a gain

59 Replies 9 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

22.50s needs to peak out some on $VERU

91 Replies 12 πŸ‘ 9 πŸ”₯

profile
@Navneet #droscrew
recently

i should have taken few $veru

85 Replies 8 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

woo $VERU what a nice short

146 Replies 7 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$VERU going

74 Replies 9 πŸ‘ 12 πŸ”₯

profile
@Navneet #droscrew
recently

$veru i rolled yesterday

40 Replies 15 πŸ‘ 6 πŸ”₯

IN
@In2Learn #droscrew
recently

$VERU and $AI today damn lost my focus

43 Replies 11 πŸ‘ 13 πŸ”₯

profile
@Navneet #droscrew
recently

$veru 15 calls feb expiry

63 Replies 10 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$VERU going

149 Replies 9 πŸ‘ 7 πŸ”₯

profile
@Navneet #droscrew
recently

$veru $vgac today was amazing

131 Replies 7 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$veru on watch tomorrow for a short

56 Replies 12 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

earnigns coming up on $VERU

99 Replies 10 πŸ‘ 9 πŸ”₯

profile
@viking #StockTraders.NET
recently

$VERU looking toppy

131 Replies 15 πŸ‘ 10 πŸ”₯

profile
@Navneet #droscrew
recently

$veru popped

105 Replies 12 πŸ‘ 14 πŸ”₯

profile
@viking #StockTraders.NET
recently

these will expire worthless. took hit on this one. still holding the APR 16 5 PUTs though > @rrivy said: long $VERU APR 16 5 PUT

71 Replies 9 πŸ‘ 13 πŸ”₯

profile
@viking #StockTraders.NET
recently

$VERU popping for no apparent reason

121 Replies 12 πŸ‘ 14 πŸ”₯

profile
@Navneet #droscrew
recently

$veru flow ! they have some presentation on jan 11

66 Replies 14 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$VERU hitting scan

120 Replies 11 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$VERU covered to early yesterday

134 Replies 12 πŸ‘ 14 πŸ”₯

WI
@WINTERTRADE #StockTraders.NET
recently

care to share with us what youve found on $veru?

101 Replies 13 πŸ‘ 14 πŸ”₯

profile
@viking #StockTraders.NET
recently

did a bit of digging into $VERU. some big red flags.

109 Replies 7 πŸ‘ 6 πŸ”₯

profile
@viking #StockTraders.NET
recently

are you short $VERU?

49 Replies 10 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

nice on $VERU

145 Replies 9 πŸ‘ 9 πŸ”₯

profile
@viking #StockTraders.NET
recently

long $VERU JAN 15 5 PUT

54 Replies 7 πŸ‘ 8 πŸ”₯

profile
@viking #StockTraders.NET
recently

long $VERU APR 16 5 PUT

75 Replies 11 πŸ‘ 14 πŸ”₯

profile
@viking #StockTraders.NET
recently

out $VERU moved position to long puts

113 Replies 9 πŸ‘ 11 πŸ”₯

profile
@viking #StockTraders.NET
recently

going short $VERU now

52 Replies 9 πŸ‘ 7 πŸ”₯

profile
@viking #StockTraders.NET
recently

out $VERU ..didnt get the pop

69 Replies 15 πŸ‘ 14 πŸ”₯

profile
@viking #StockTraders.NET
recently

im gonna go long $VERU here thinking spike into close but very short leash.

43 Replies 7 πŸ‘ 8 πŸ”₯

profile
@viking #StockTraders.NET
recently

$VERU wouldnt be suprised if they pumped it into close then did an offering after the bell

134 Replies 6 πŸ‘ 10 πŸ”₯

profile
@viking #StockTraders.NET
recently

did $VERU do an offering yet?

138 Replies 15 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

sellers lining up on $VERU

67 Replies 9 πŸ‘ 8 πŸ”₯

profile
@maletone #StockTraders.NET
recently

just finished signing and while I was signing got some fills on $VERU short in AH's

136 Replies 6 πŸ‘ 13 πŸ”₯

profile
@Chano #StockTraders.NET
recently

@maletone how is your $VERU going? I see more and more fades

42 Replies 7 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

more fails $VERU

122 Replies 10 πŸ‘ 12 πŸ”₯

Key Metrics

Market Cap

547.43 M

Beta

0.89

Avg. Volume

678.97 K

Shares Outstanding

79.68 M

Yield

0%

Public Float

0

Next Earnings Date

2021-08-12

Next Dividend Date

Company Information

Veru Inc. is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and breast cancer. The Veru prostate cancer pipeline includes VERU-111, VERU-100, and Zuclomiphene citrate. VERU-111 is an oral, first-in-class, new chemical entity that targets, crosslinks, and disrupts alpha and beta tubulin subunits of microtubules for the treatment of metastatic castration and androgen receptor resistant prostate cancer. VERU-100 is a novel, proprietary peptide formulation designed to address the current limitations of commercially available androgen deprivation therapies (ADT) for advanced prostate cancer. Zuclomiphene citrate is an oral nonsteroidal estrogen receptor agonist being developed to treat hot flashes, a common side effect caused by ADT in men with advanced prostate cancer. The Veru breast cancer pipeline includes enobosarm for AR+/ER+/HER2- metastatic breast cancer and VERU-111 for taxane resistant metastatic triple negative breast cancer. Enobosarm is an oral, first-in-class, new chemical entity, selective androgen receptor agonist that targets and activates the androgen receptor in AR+/ER+/HER2- metastatic breast cancer without unwanted masculinizing side effects. VERU-111 is also being advanced into a Phase 3 trial for the treatment of hospitalized patients with COVID-19 who are at high risk for acute respiratory distress syndrome.

CEO: Mitchell Steiner

Website:

HQ: 48 NW 25th St Ste 102 Miami, 33127-4442 Florida

Related News

  • Intrado Digital Media

    Veru to Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call on August 12th

    29 Jul 2021, 12:30
  • Benzinga

    Global Condoms Market to Reach $11 Billion by 2027

    15 Jul 2021, 09:43
  • Seeking Alpha

    Veru provides update on Phase 1b/2 study of sabizabulin in men with prostate cancer

    28 Jun 2021, 13:04
  • Intrado Digital Media

    Veru Announces the Presentation of a Phase 1b/2 Clinical Study Update for Sabizabulin (VERU-111) in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 European Association of Urology Annual Congress

    28 Jun 2021, 12:30
  • Seeking Alpha

    Enrollment underway in Veru''s mid-stage study of VERU-100 in hormone sensitive prostate cancer

    10 Jun 2021, 12:45